BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  BIOREM Reports Significant Revenue and Income Growth for Third Quarter

  BIOREM today announced its results for the three and nine-month periods ended September 30, 2017.

  November 15, 2017

   · 

  3 min read
• BioCapital

  Incyte Announces Initiation of Pivotal Clinical Trial of Ruxolitinib (Jakafi®) for the Treatment of Essential Thrombocythemia

  The study is expected to enroll approximately 120 patients, 18 years or older, diagnosed with ET who are resistant to or intolerant of HU.

  November 15, 2017

   · 

  6 min read
• Business

  The Medicines Company Names Dr. Fred Eshelman as Executive Chairman; Appoints Geno Germano to Its Board of Directors

  These appointments are effective immediately.

  November 15, 2017

   · 

  3 min read
• Bausch & Lomb Helps to Recycle More Than One Million Units of Contact Lens Materials Within First Year of Launching the ONE by ONE Recycling Program

  Valeant wholly owned subsidiary, Bausch & Lomb, today announced that its unique ONE by ONE Recycling Program has recycled a combined total of more than one million used contact lenses, blister packs and top foils in less than one year since its launch.

  November 15, 2017

   · 

  4 min read
• Drug Development

  Cingulate Therapeutics to Present in Vivo Pharmacokinetic Data Demonstrating Consistent Tri-Phasic Release Profile of Lead Compound at the AAPS Annual Meeting

  The study evaluated CTX-1301, Cingulate’s proprietary, first-line stimulant medication for the treatment of ADHD, utilizing an innovative, proprietary timed release technology OralogiK developed by CTx’s partner BDD.

  November 15, 2017

   · 

  4 min read
• 

  FDA

  Alcyone Lifesciences Snags FDA OK for the Alivio System for the Treatment of Hydrocephalus

  This comes on the heels of Alcyone receiving the EU CE Mark last month.

  November 15, 2017

   · 

  5 min read
• Business

  Turnstone Biologics Appoints Dr. Mike Burgess as President of Research and Development

  Dr. Burgess joins from Bristol-Myers Squibb, where he was senior vice president of development across multiple therapeutic areas.

  November 15, 2017

   · 

  3 min read
• Business

  IRX Therapeutics Appoints Luba Greenwood to Board of Directors

  Luba Greenwood brings to IRX a wealth of pharmaceutical and biotechnology industry experience.

  November 15, 2017

   · 

  3 min read
• BMG Pharma is Pleased to Announce Positive Clinical Results on GelX the First Breakthrough Product to Achieve Prevention of Oral Mucositis in Cancer Patients

  The new clinical data, (conducted under GCP principles) from 149 adult and paediatric patients has shown unique results for the first time, with 36,2% of the patients having a complete prevention of oral mucositis during cancer therapy.

  November 15, 2017

   · 

  2 min read
• Bio NC

  LabCorp Announces New Expanded Use for PD-L1 Test With Bristol-Myers Squibb’s OPDIVO

  The PD-L1 IHC 28-8 pharmDx assay was developed by Agilent’s Dako pathology division.

  November 15, 2017

   · 

  5 min read